These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9262476)

  • 1. A macrophage invasion mechanism of pathogenic mycobacteria.
    Schorey JS; Carroll MC; Brown EJ
    Science; 1997 Aug; 277(5329):1091-3. PubMed ID: 9262476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secret lives of the pathogenic mycobacteria.
    Cosma CL; Sherman DR; Ramakrishnan L
    Annu Rev Microbiol; 2003; 57():641-76. PubMed ID: 14527294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial immunology: a new mechanism for immune subversion.
    Lachmann PJ
    Curr Biol; 1998 Jan; 8(3):R99-R101. PubMed ID: 9443910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis and the complement system.
    Schlesinger LS
    Trends Microbiol; 1998 Feb; 6(2):47-9; discussion 49-50. PubMed ID: 9507637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement in Mycobacterium avium pathogenesis: in vivo and in vitro analyses of the host response to infection in the absence of complement component C3.
    Bohlson SS; Strasser JA; Bower JJ; Schorey JS
    Infect Immun; 2001 Dec; 69(12):7729-35. PubMed ID: 11705954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources of variability in assays of the interaction of mycobacteria with mononuclear phagocytes: of mice and men.
    Ellner JJ
    Res Microbiol; 1990 Feb; 141(2):237-40. PubMed ID: 2111925
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria.
    McGarvey JA; Wagner D; Bermudez LE
    Clin Exp Immunol; 2004 Jun; 136(3):490-500. PubMed ID: 15147351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic Mycobacterium bovis strains differ in their ability to modulate the proinflammatory activation phenotype of macrophages.
    Andrade MR; Amaral EP; Ribeiro SC; Almeida FM; Peres TV; Lanes V; D'Império-Lima MR; Lasunskaia EB
    BMC Microbiol; 2012 Aug; 12():166. PubMed ID: 22863292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
    Stokes RW; Haidl ID; Jefferies WA; Speert DP
    J Immunol; 1993 Dec; 151(12):7067-76. PubMed ID: 8258711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterial protein HbhA binds human complement component C3.
    Mueller-Ortiz SL; Wanger AR; Norris SJ
    Infect Immun; 2001 Dec; 69(12):7501-11. PubMed ID: 11705926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoonotic aspects of Mycobacterium bovis and Mycobacterium avium-intracellulare complex (MAC).
    Biet F; Boschiroli ML; Thorel MF; Guilloteau LA
    Vet Res; 2005; 36(3):411-36. PubMed ID: 15845232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular killing of mycobacteria.
    Crowle AJ
    Res Microbiol; 1990 Feb; 141(2):231-6. PubMed ID: 2111924
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.
    Rastogi N; Cadou S; Hellio R
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):278-91. PubMed ID: 2071985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
    Fujita T; Inoue T; Ogawa K; Iida K; Tamura N
    J Exp Med; 1987 Nov; 166(5):1221-8. PubMed ID: 2445886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria.
    Sherman DR; Sabo PJ; Hickey MJ; Arain TM; Mahairas GG; Yuan Y; Barry CE; Stover CK
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6625-9. PubMed ID: 7604044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killing intracellular mycobacteria in in vitro macrophage systems: what may be the role of known host microbicidal mechanisms?
    Rastogi N
    Res Microbiol; 1990 Feb; 141(2):217-30. PubMed ID: 2111923
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage--Mycobacterium tuberculosis interactions: role of complement receptor 3.
    Velasco-Velázquez MA; Barrera D; González-Arenas A; Rosales C; Agramonte-Hevia J
    Microb Pathog; 2003 Sep; 35(3):125-31. PubMed ID: 12927520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid.
    Ferguson JS; Weis JJ; Martin JL; Schlesinger LS
    Infect Immun; 2004 May; 72(5):2564-73. PubMed ID: 15102764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rv2617c and P36 are virulence factors of pathogenic mycobacteria involved in resistance to oxidative stress.
    Forrellad MA; Vázquez CL; Blanco FC; Klepp LI; García EA; Rocha RV; Luciana V; Bigi MM; Gutierrez MG; Bigi F
    Virulence; 2019 Dec; 10(1):1026-1033. PubMed ID: 31782338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple routes of complement activation by Mycobacterium bovis BCG.
    Carroll MV; Lack N; Sim E; Krarup A; Sim RB
    Mol Immunol; 2009 Oct; 46(16):3367-78. PubMed ID: 19698993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.